4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one

C77H104ClN15O6 — CID 158072825

IUPAC4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one
SMILESCCCCOc1nc(N)c2c(n1)N(Cc1cc(Cl)cc(CN3CCCC3)c1)CCC(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)C1CCCC1C(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC1(CC1)C(=O)C2
InChIInChI=1S/C27H37N5O2.C26H35N5O2.C24H32ClN5O2/c1-2-3-14-34-27-29-25(28)22-16-24(33)21-10-7-11-23(21)32(26(22)30-27)18-20-9-6-8-19(15-20)17-31-12-4-5-13-31;1-2-3-13-33-25-28-23(27)21-15-22(32)26(9-10-26)18-31(24(21)29-25)17-20-8-6-7-19(14-20)16-30-11-4-5-12-30;1-2-3-10-32-24-27-22(26)21-14-20(31)6-9-30(23(21)28-24)16-18-11-17(12-19(25)13-18)15-29-7-4-5-8-29/h6,8-9,15,21,23H,2-5,7,10-14,16-18H2,1H3,(H2,28,29,30);6-8,14H,2-5,9-13,15-18H2,1H3,(H2,27,28,29);11-13H,2-10,14-16H2,1H3,(H2,26,27,28)
InChIKeyFMAAYTASDVOXNZ-UHFFFAOYSA-N
MW1371.23 g/mol
LogP11.89
Rot. Bonds24

About 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one

4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one (PubChem CID 158072825) has the molecular formula C77H104ClN15O6 and a molecular weight of 1371.23 g/mol. Its IUPAC name is 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one.

Molecular Properties

Compound Name4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one
PubChem CID158072825
Molecular FormulaC77H104ClN15O6
Molecular Weight1371.23 g/mol
Exact Mass1369.80
IUPAC Name4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one
SMILESCCCCOc1nc(N)c2c(n1)N(Cc1cc(Cl)cc(CN3CCCC3)c1)CCC(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)C1CCCC1C(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC1(CC1)C(=O)C2
InChIInChI=1S/C27H37N5O2.C26H35N5O2.C24H32ClN5O2/c1-2-3-14-34-27-29-25(28)22-16-24(33)21-10-7-11-23(21)32(26(22)30-27)18-20-9-6-8-19(15-20)17-31-12-4-5-13-31;1-2-3-13-33-25-28-23(27)21-15-22(32)26(9-10-26)18-31(24(21)29-25)17-20-8-6-7-19(14-20)16-30-11-4-5-12-30;1-2-3-10-32-24-27-22(26)21-14-20(31)6-9-30(23(21)28-24)16-18-11-17(12-19(25)13-18)15-29-7-4-5-8-29/h6,8-9,15,21,23H,2-5,7,10-14,16-18H2,1H3,(H2,28,29,30);6-8,14H,2-5,9-13,15-18H2,1H3,(H2,27,28,29);11-13H,2-10,14-16H2,1H3,(H2,26,27,28)
InChIKeyFMAAYTASDVOXNZ-UHFFFAOYSA-N
XLogP11.89
TPSA253.74 Ų
H-Bond Donors3
H-Bond Acceptors21
Rotatable Bonds24
Heavy Atoms99
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001371.23
LogP ≤ 511.89
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one?
The IUPAC name of 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one (CID 158072825) is 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one.
What is the SMILES notation for 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one?
The canonical SMILES for 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one is CCCCOc1nc(N)c2c(n1)N(Cc1cc(Cl)cc(CN3CCCC3)c1)CCC(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)C1CCCC1C(=O)C2.CCCCOc1nc(N)c2c(n1)N(Cc1cccc(CN3CCCC3)c1)CC1(CC1)C(=O)C2.
What is the InChIKey of 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one?
The InChIKey is FMAAYTASDVOXNZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H37N5O2.C26H35N5O2.C24H32ClN5O2/c1-2-3-14-34-27-29-25(28)22-16-24(33)21-10-7-11-23(21)32(26(22)30-27)18-20-9-6-8-19(15-20)17-31-12-4-5-13-31;1-2-3-13-33-25-28-23(27)21-15-22(32)26(9-10-26)18-31(24(21)29-25)17-20-8-6-7-19(14-20)16-30-11-4-5-12-30;1-2-3-10-32-24-27-22(26)21-14-20(31)6-9-30(23(21)28-24)16-18-11-17(12-19(25)13-18)15-29-7-4-5-8-29/h6,8-9,15,21,23H,2-5,7,10-14,16-18H2,1H3,(H2,28,29,30);6-8,14H,2-5,9-13,15-18H2,1H3,(H2,27,28,29);11-13H,2-10,14-16H2,1H3,(H2,26,27,28).
What are the key properties of 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one?
4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one has a molecular weight of 1371.23 g/mol, XLogP of 11.89, 24 rotatable bonds, 3 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 4-amino-2-butoxy-9-[[3-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]methyl]-7,8-dihydro-5H-pyrimido[4,5-b]azepin-6-one;4-amino-2-butoxy-9-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]spiro[5,8-dihydropyrimido[4,5-b]azepine-7,1'-cyclopropane]-6-one;11-amino-13-butoxy-2-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-2,12,14-triazatricyclo[8.4.0.03,7]tetradeca-1(14),10,12-trien-8-one is sourced from PubChem (CID 158072825), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).